Facebook
Twitter
LinkedIn
Forward2024 Allied Health Professionals Meeting On-Demand Package
Log in to see your correct pricing, as SGO members receive a discount. All content has been added to the course.
This course includes all CE-eligible sessions recorded at the SGO 2024 Allied Health Professionals Meeting held in Charlotte, North Carolina on September 27-29, 2024. CE is available for the on-demand content through April 7, 2025. After that date registrants of the course will still be able to access the content.
- Opening Session: Rare Tumors - Anil Sood, MD
- ADC’s, Easy as 1,2,3 - Jennifer MacDonald, PharmD, BCOP
- Putting FIGO Staging Updates into Practice - Erin Crane, MD
- Starting a Sexual Health Clinic - Nicole Dreibelbis, WHNP-BC and Nora Lersch, DNP, FNP-BC, AOCNP
- Tumor Board - Whitney Graybill, MD, Jubilee Brown, MD, R. Wendel Naumann, MD
- ERAS and Beyond: Prevention and Management of Post Operative Complications in Gynecologic Oncology - Michelle Davis, MD
- Updates in Clinical Trials - Joshua Cohen, MD
- Management of Immunotherapy Toxicities in GYN Oncology - Kathleen Lutz, NP
- Increasing Knowledge and Support in Survivorship - Jessica Walchonski, PA-C, MMS
- Menopause Management for Gyn Cancer Survivors- Your Complete Menopause Toolkit - Rachel Frankenthal, MMS, PA-C, MPH, MSCP
- Lifestyle Modifications for Cancer Patients - Jenna Unke, PA-C
- Patient Panel - Featuring 3 survivors
- Demystifying Cancer Pain Management - Molly Silver, APRN
- Managing Common Side Effects from Pelvic Radiotherapy - Benjamin Moeller, MD
- Reclaiming Intimacy: How a Cancer Diagnosis Can Impact Sexuality and Intimacy - Nicole Dreibelbis, WHNP-BC
- Pathology of HPV-Associated Neoplasia in the Gynecologic Tract - Levon Katsakhyan, MD
Target Audience
Nurse Practitioners, Physician Assistants/Associates, APPs, NPs, PAs, SGO Members
Learning Objectives
1. Identify rare tumors seen in gynecologic oncology and assess how to treat them.
2. Discuss patient scenarios and compare treatment plans to formulate a recommendation.
3. Review updates in pertinent clinical trials and describe implications for patient care.
Additional Information
| Attachment | Size |
|---|---|
 Final Meeting Schedule | 287.68 KB |
| Learner Notification | 205.68 KB |
Available Credit
- 13.00 AMA PRA Category 1 Credit™
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this Enduring material for a maximum of 13.00 Enduring AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 13.00 AMA PRA Category 1 Credits™- For Non-physicians In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PAs may claim a maximum of 13.00 Enduring Category 1 credits for completing this activity. - 13.00 CNE Contact Hours In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this activity for a maximum of 13.00 Enduring ANCC contact hours. - 13.00 Participation